Cytology of Pericardial Effusion due to Malignancy

1. GORNIK H.L., GERHARD-HERMAN M., BECKMAN J.A. Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol. 2005; 2 3(22):5211-6.10.1200/JCO.2005.00.745Search in Google Scholar

2. MAISCH B.I., SEFEROVIĆ P.M., RISTIĆ A.D., et al. Guidelines on the diagnosis and management of pericardial diseases executive summary; The Task force on the diagnosis and management of pericardial diseases of the European society of cardiology. Eur Heart J. 2004 Apr; 25(7):587-610.10.1016/j.ehj.2004.02.002Search in Google Scholar

3. REFAAT M.M., KATZ W.E. Neoplastic Pericardial Effusion. Clinical Cardiology 2011; 34(10):593-8.10.1002/clc.20936Search in Google Scholar

4. LEWINTER M.M., TISCHLER M.D. Pericardial diseases. In: Bonow R.O., Mann D.L., Zipes D.P., Libby P., eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Ed 9. Philadelphia, 2011, Saunders, 1651-1670.Search in Google Scholar

5. SAGRISTÀ-SAULEDA J., MERCÉ J., PERMANYER-MIRALDA G., SOLER-SOLER J. Clinical clues to the causes of large pericardial effusions. Am J Med. 2000; 109(2):95-101.10.1016/S0002-9343(00)00459-9Search in Google Scholar

6. MAGGIOLINI S., OSCULATI G., VITALE G. Utility and safety of diagnostic pericardiocentesis. European Heart Journal 2005; 26(10):1046-7.10.1093/eurheartj/ehi240Search in Google Scholar

7. SIDAWY M.K, ALI S.Z. Fine needle aspiration cytology. Elsevier Health Sciences, 2007.Search in Google Scholar

8. RIZZARDI C., BARREZI E., BROLLO A., CASSETTI P., SCNEIDER M., MELATO M. Primary pericardial mesothelioma in an asbestos-exposed patient with previous heart surgery. Anticancer Research 2010; 30 (1):1323-6.Search in Google Scholar

9. KWON H.Y., CHO K.I., KIM S.M., et al. A rare case with primary undifferentiated carcinoma of pericardium. Journal of Cardiovascular Ultrasound. 2010; 18(3):104-107.10.4250/jcu.2010.18.3.104Search in Google Scholar

10. PETCU D.P., PETCU C., POPESCU C.F., BĂTĂIOSU C., ALEXANDRU D. Clinical and cytological correlations in pericardial effusions with cardiac tamponade. Rom J Morphol Embryol. 2009; 50(2):251-6.Search in Google Scholar

11. KOSS G.L., MELAMED M.R., Effusions in the absence of cancer and effusions in the presence of cancer. In: Koss G.L., Melamed M.R. (eds), Koss’ diagnostic cytology and its histopathologic bases, 5th edition, Lippincott Williams & Wilkins, Philadelphia, 2006.Search in Google Scholar

12. REUTER H., BURGESS L., VAN VUUREN W., DOUBELL A., Diagnosing tuberculous pericarditis. QJM, 2006; 99(12):827-39.10.1093/qjmed/hcl123Search in Google Scholar

13. FIOCCO M., KRASNA M.J., The management of malignant pleural and pericardial effusions. Hematol Oncol Clin North Am 1997; 11(2):253-65.10.1016/S0889-8588(05)70429-9Search in Google Scholar

14. WANG P.C., YANG K.Y., CHAO J.Y., LIU J.M., PERNG R.P., YEN S.H., Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest 2000; 118(3):744-749.10.1378/chest.118.3.74410988197Search in Google Scholar

15. DRAGOESCU E.A, LIU L. Pericardial fluid cytology: An analysis of 128 specimens over a 6 year period. Cancer Cytopathol. 2013, 121:242-251.10.1002/cncy.2124623362233Search in Google Scholar

16. HAE-OK JUNG. Pericardial effusion and pericardiocentesis: Role of echocardiography. Korean Circ J. 2012; 42(11): 725-34.10.4070/kcj.2012.42.11.725351870523236323Search in Google Scholar

17. KARATOLIOS K., PANKUWEIT S., MAISCH B. Diagnostic value of biochemical biomarkers in malignant and non-malignant pericardial effusion. Heart Fail Rev. 2013; 18(3):337-44. 10.1007/s10741-012-9327-x22638889Search in Google Scholar